Drug & intervention
Lovaza
RxCUI 278346
RxNorm ingredient and formulation relationships
Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.
Loading RxNorm relationships…
Clinical trials
10 shownImmunonutrition for Diabetic Foot UlcersNCT05281562 · 2023-02-08
TERMINATEDQUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 InhibitorsNCT03169738 · 2018-02-01
WITHDRAWNQUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based ChemotherapyNCT03175666 · 2017-12-01
WITHDRAWNFish Oils and Adipose Inflammation ReductionNCT02010359 · 2014-06-01
COMPLETEDDietary Energy Restriction and Omega-3 Fatty Acids on Mammary TissueNCT01784042 · 2013-03-01
WITHDRAWNThe Impact of Omega Three Fatty Acids on Vascular Function in HIVNCT01041521 · 2010-01-01
COMPLETEDOmega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated HypertriglyceridemiaNCT00833976 · 2009-07-01
COMPLETEDPilot Placebo Controlled Study With Lovaza in Cardiovascular DiseaseNCT01001767 · 2009-04-01
COMPLETEDHuman Immunodeficiency Virus (HIV), Arterial Dysfunction, Lipids, Lovaza (HALO) TrialNCT00795717 · 2008-07-01
COMPLETEDEffects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes (T2DMNCT00577590 · 2003-10-01
COMPLETEDConditions being studied
HIV Infection2Bipolar Disorder1Breast Cancer1Cardiovascular Disease1Diabetes Mellitus1Diabetes Mellitus, Type II1Diabetic Foot Ulcer1Diabetic Peripheral Neuropathy1Heart Disease1High Triglyceride Level1High Triglycerides1HIV Infections1Hypercholesterolemia1Non-small Cell Lung Cancer1Obesity1Schizoaffective Disorder1Schizophrenia1Triple Negative Breast Cancer1
Research locations
Leading sponsors
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.